NCT02992327View on ClinicalTrials.gov

Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 30, 2015

Primary Completion Date

August 6, 2018

Study Completion Date

August 6, 2018

Conditions
Concussion, MildNeurocognitive Dysfunction
Trial Locations (1)

55101

Regions Hospital, Saint Paul

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

lead

HealthPartners Institute

OTHER

NCT02992327 - Biomarker Levels as A Predictor of Concussion Severity OUTcomes (BlacOut) | Biotech Hunter | Biotech Hunter